365 A Phase 1b Open-label, Dose-escalation Study of the Safety and Pharmacology of GDC-0941 in Combination with Erlotinib in Patients with Advanced Solid Tumors
Lolkema, M, Leong, S, Voest, E, Freas, E, Shankar, G, Brachmann, R.K, Moss, R.A, Stein, M.N, Mergui-Roelvink, M, Schellens, J.H.M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
9012 POSTER DISCUSSION A Phase lb Study to Evaluate the PI3-Kinase Inhibitor GDC-0941 With Paclitaxel (P) and Carboplatin (C), With and Without Bevacizumab (BEV), in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Groen, H, Adjei, A.A, Dy, G.K, Ware, J.A, Shankar, G, Brachmann, R.K, Besse, B, Bahleda, R.K, Gomez-Roca, C, Soria, J
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Functional census of mutation sequence spaces: the example of p53 cancer rescue mutants
Danziger, S.A., Swamidass, S.J., Jue Zeng, Dearth, L.R., Qiang Lu, Chen, J.H., Cheng, J., Hoang, V.P., Saigo, H., Luo, R., Baldi, P., Brachmann, R.K., Lathrop, R.H.
Published in IEEE/ACM transactions on computational biology and bioinformatics (01.04.2006)
Published in IEEE/ACM transactions on computational biology and bioinformatics (01.04.2006)
Get full text
Journal Article
421 A Phase Ib study to evaluate the pan-PI3K inhibitor GDC-0941 with paclitaxel and carboplatin with and without bevacizumab in non-small cell lung cancer patients
Soria, J.C, Gomez-Roca, C.A, Ware, J.A, Adjei, A.A, Brachmann, R.K, Groen, H.J.M
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article